HMIRC Notices - Decisions and Orders

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

February 2, 2008

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Haz-ardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS), listed below.

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	MSDS Preparation Date (As shown on the MSDS)	Date of Decision
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	IC 191	6036	July 31, 2006	October 15, 2007
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® AP-1	6048	9/10/2007	October 15, 2007
Hydro Technologies (Canada) Inc., Sainte-Foy, Québec	HY BRITE® HT-115	6087	Juin 2007	November 29, 2007
Schlumberger Canada Limited, Calgary, Alberta	Surfactant B220	6170	11 June 2007	October 10, 2007
Ciba Specialties Canada Inc., Mississauga, Ontario	Irgalite Rubine 4BFP	6192	19-Apr-2005	October 15, 2007
Diacon Technologies Ltd., Richmond, British Columbia	CEDARBRITE formerly Cedarbrite	6216	February 27, 2007	October 9, 2007
Baker Petrolite Corporation, Sugar Land, Texas	TOLAD® 9022 FUEL STABILITY ADDITIVE	6257	9/27/2005	November 15, 2007
Nalco Canada Co., Burlington, Ontario	NALCO® EC6032A	6258	2005/09/12	November 23, 2007
Süd-Chemie Inc., Louisville, Kentucky	Styromax® 3	6259	03/08/2007	October 23, 2007
Cognis Canada Corporation, Mississauga, Ontario	CAPCURE 3830-81	6260	09/12/2005 (English) 09/08/2005 (French)	October 19, 2007
Cytec Industries Inc., West Paterson, New Jersey	AERO® XD5002 Promoter	6267	12/06/2006	November 6, 2007
Innospec Fuel Specialties, LLC formerly Octel Starreon, LLC, Newark, Delaware	FOA-91 ei1 formerly Octel Starreon FO-91 ei1	6268	07 June 2006	October 18, 2007
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMOLUBE® 104 PG	6278	19/2/2005	October 25, 2007
Nalco Canada Co., Burlington, Ontario	EC9541A	6285	2005/11/18	November 26, 2007
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	MORWET® B POWDER	6288	1/20/2006	October 26, 2007
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	MORWET® D-425 POWDER	6289	10/30/2006	October 26, 2007
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	WITCOMUL® 4050	6301	11/9/2005	December 13, 2007
Schlumberger Canada Limited, Calgary, Alberta	Corrosion Inhibitor A262	6306	26 April 2007	December 27, 2007
Nalco Canada Co., Burlington, Ontario	NALCO® EC5494A	6336	2005/12/01	November 27, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-0018 COLORTREND® PLUS(TM) TITANIUM WHITE	6394	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-0426 COLORTREND® PLUS(TM) MAGENTA	6395	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-0836 COLORTREND® PLUS(TM) ORGANIC RED	6396	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-1045 COLORTREND® PLUS(TM) RED OXIDE	6397	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-1572 COLORTREND® PLUS(TM) BROWN OXIDE	6398	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-1811 COLORTREND® PLUS(TM) YELLOW OXIDE	6399	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-2009 COLORTREND® PLUS(TM) RAW UMBER	6400	06/18/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-2551 COLORTREND® PLUS(TM) ORGANIC YELLOW	6401	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-5511 COLORTREND® PLUS(TM) PHTHALO GREEN	6402	06/21/2007	November 8, 2007
Evonik Degussa Canada, Inc., formerly Degussa Canada Inc., Brampton, Ontario	802-9907 COLORTREND® PLUS(TM) LAMP BLACK	6403	06/21/2007	November 8, 2007
Cognis Canada Corporation, Mississauga, Ontario	PHOTOMER 3215	6404	12/06/2005	November 19, 2007
Cognis Canada Corporation, Mississauga, Ontario	WATERPOXY 1455	6405	12/07/2005	December 5, 2007
Hexion Specialty Chemicals Canada Inc., Oshawa, Ontario	Fentak™ F0306H	6407	08-DEC-2006	December 20, 2007
Schlumberger Canada Limited, Calgary, Alberta	Gelling Agent ClearFRAC XT J590 formerly Developmental Gelling Agent XE119	6413	15 June 2007	November 21, 2007
Raybo Chemical Company, Huntington, West Virginia	RAYBO 90 NORUST NF formerly Raybo 90 NoRust NF	6414	Jan12/05 (English) JAN12/05 (French)	November 14, 2007
Huntsman Corp., The Woodlands, Texas	RUBINATE® 1790	6420	6/19/2007	December 13, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	CA 5051	6475	August 3, 2006	November 26, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	Wetsol 1 Mutual Solvent	6482	August 14, 2006	December 21, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	Wetsol 2 Mutual Solvent	6483	August 14, 2006	December 21, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	WC 5000 Paraffin Solvent	6484	August 14, 2006	December 21, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	WC 6000 Asphaltene Solvent	6485	August 14, 2006	December 21, 2007
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	WC 7000 Paraffin / Asphaltene Solvent	6486	August 3, 2006	December 21, 2007
Buckeye International, Inc., Maryland Heights, Missouri	BUCKEYE BLUE	6635	6/1/2006 (English) 6/01/06 (French)	October 30, 2007
Innospec Fuel Specialties, LLC Newark, Delaware formerly Octel Starreon, LLC, Littleton, Colorado	OLI-9070 formerly Octel Starreon OLI-9070	6648	05 June 2006	November 22, 2007
Acheson Colloids Company, Port Huron, Michigan	Emralon 310-B/Emralon 310B	6677	5/17/2006 (English) 06/05/17 (French)	November 30, 2007

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on December 11, 2004, listed the subject of the claim bearing Registry Number 6036 to be the chemical identity of four ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients and the concentration of four ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on December 11, 2004, listed the subject of the claim bearing Registry Number 6048 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of five ingredients.

3. The Notice of Filing published in the Canada Gazette, Part I, on May 21, 2005, listed the subject of the claim bearing Registry Number 6170 to be the chemical identity of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of two ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, incorrectly listed the product identifier for the controlled product associated with the claim bearing Registry Number 6257 as TOLAD®FUEL STABILITY ADDITIVE. The correct product identifier is TOLAD®9022 FUEL STABILITY ADDITIVE.

5. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6268 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

6. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6306 to be the chemical identity of six ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of seven ingredients.

7. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6407 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

8. The Notice of Filing published in the Canada Gazette, Part I, on February 4, 2006, listed the subject of the claim bearing Registry Number 6414 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

9. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subject of the claim bearing Registry Number 6475 to be the chemical identity and concentration of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient and the concentration of two ingredients.

10. The Notice of Filing published in the Canada Gazette, Part I, on April 1, 2006, listed the subjects of the claims bearing Registry Numbers 6482, 6483, 6485 and 6486 to be the chemical identity and concentration of four, three, four and five ingredients respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identity of three ingredients and the concentration of four ingredients, the chemical identity of two ingredients and the concentration of three ingredients, the chemical identity of three ingredients and the concentration of four ingredients and the chemical identity of four ingredients and the concentration of five ingredients, respectively.

There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the MSDS in respect of which the claim bearing Registry Number 6635 was filed complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

In the case of the claims bearing Registry Numbers 6170, 6306 and 6413 being claims from an employer in the province of Alberta, the screening officer found that the MSDSs relating to these claims did not comply with the applicable disclosure requirements of the Occupational Health and Safety Code 2006 of the Province of Alberta.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 6036

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose a lower LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

2. Disclose a lower Exposure Limit Value ACGIH TLV–TWA (C) for one of the confidential hazardous ingredients;

3. Disclose an oral LD₅₀ value and a lower LC₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

4. Disclose that acute inhalation of an ingredient in the controlled product has been shown to cause damage to the nose and throat in laboratory animals;

5. Disclose that an ingredient in the controlled product has been shown to cause skin corrosion in laboratory animals;

6. In relation to the first aid information shown on the MSDS for ingestion, remove the statements to give large amounts of water and to induce vomiting and replace them with a statement such as the following: Do not induce vomiting. If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

7. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current reference to 15 minutes and replace it with a time of 30 minutes;

8. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to 15 minutes and replace it with a time of 30 minutes;

9. Add halogen oxides to and remove oxides of nitrogen from the list of hazardous combustion products.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6048

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Add formaldehyde and oxides of sulfur to the list of hazardous decomposition or combustion products;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 6087

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that acute exposure to the controlled product can be corrosive to the eyes and skin.

Registry Number 6170

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has shown positive test results in an in vivo screening test for mutagenicity;

2. Disclose that an ingredient in the controlled product has been shown to cause developmental effects in laboratory animals at maternally toxic dose levels;

3. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the liver and the kidney of laboratory animals;

4. Disclose that subchronic dermal exposure to an ingredient in the controlled product has been shown to cause effects on the liver in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6192

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose oxides of carbon, sulphur and nitrogen as hazardous combustion products.

Registry Number 6216

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to 20 minutes and replace it with a time of at least 30 minutes;

2. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current reference to 20 minutes and replace it with a time of at least 30 minutes and add that medical attention should be obtained immediately;

3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give large amounts of water and replace it with a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

4. Disclose an Exposure Limit Value for one of the confidential hazardous ingredients;

5. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on bone growth in laboratory animals.

Registry Number 6257

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correct the impression that ethylbenzene, 1,2,4-trimethylbenzene, and naphthalene are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.

Registry Number 6258

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current time frame and replace it with a time of "at least thirty minutes";

2. Disclose that an ingredient in the controlled product is incompatible with alkylaluminum solutions;

3. Disclose an LD₅₀ (oral, rat) value of 1 100 mg/kg for zinc chloride;

4. Disclose a lower LD₅₀ (dermal, rabbit) value of 15 800 mg/kg for methanol;

5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Registry Number 6259

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. In relation to the period of time shown on the MSDS for flushing the eyes with water should eye contact occur, delete the current reference to at least 30 minutes and replace it with a time of at least 60 minutes. Further disclose instructions to the effect that any dry or wet product on the face should be quickly and gently blotted away. Indicate that immediate medical attention should be obtained;

3. In relation to the period of time shown on the MSDS for flushing the skin with water should skin contact occur, delete the current reference to at least 30 minutes and replace it with a time of at least 60 minutes. Indicate that immediate medical attention should be obtained;

4. Disclose that ingredients in the controlled product are incompatible with strong oxidizing agents and acids. Disclose also that exposure to water produces heat and results in the production of corrosive substances.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6260

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes.

Registry Number 6267

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS registry number and percent concentration;

2. Disclose the Exposure Limit Value AIHA WEEL–TWA = 0.001 ppm (skin) for quinoline;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed.

Registry Number 6268

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum) heavy arom.

Registry Number 6278

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen and chlorine as well as ammonia to the list of hazardous combustion products.

Registry Number 6285

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Numbers 6288 and 6289

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Amend section 3 to disclose that nausea, vomiting and respiratory irritation are symptoms which occur by ingestion and inhalation as routes of entry;

2. Remove or change contradictory statements concerning the skin irritation properties of the controlled product.

Registry Number 6301

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose oxides of carbon and oxides of nitrogen as hazardous thermal decomposition products;

2. Remove the statement that the controlled product is practically non-toxic in contact with the skin;

3. Disclose that absorption of an ingredient in the controlled product has caused gastrointestinal, kidney and lung damage;

4. Disclose that a case of ingestion of an ingredient in the controlled product affected the central nervous system and caused abdominal pain as well as swelling in the lungs;

5. Disclose that inhalation of an ingredient in the controlled product has caused gastrointestinal tract disturbances and kidney damage.

Acknowledgement: Subsequent to the review of the MSDSof-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6306

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A;

2. Disclose the presence of two additional confidential hazardous ingredients in the controlled product;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

5. Remove the ACGIH TLV designation from the disclosed exposure limit value for nuisance dusts;

6. Add alkylaluminum solutions and aluminum powder to the list of incompatible materials;

7. Add oxides of chlorine to the list of hazardous decomposition products;

8. Disclose that an ingredient in the controlled product has been shown to cause dermal sensitization in laboratory animals;

9. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

10. Disclose an LD₅₀ (oral) range value for one of the confidential hazardous ingredients.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6336

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Either disclose an oral, rat LD₅₀ value and a lower bound to the dermal, rabbit LD₅₀ value for one of the confidential hazardous ingredients or else disclose calculated values for the controlled product as a whole;

2. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity.

Registry Numbers 6394 to 6403, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Registry Number 6400: Disclose the lower CAD BC OEL exposure limit value = 0.025 mg/m³ for silica, crystalline quartz;

2. Registry Numbers 6396 and 6401: Add oxides of chlorine to the list of hazardous decomposition or combustion products.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Number 6404

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correct the contradictory information concerning the controlled product's potential for skin sensitization.

Registry Number 6405

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals;

2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 6407

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give large quantities of water to drink;

3. Disclose oxides of carbon, phosphorus and nitrogen as hazardous combustion products;

4. Disclose an LC₅₀ (8 hours, rat) value of 12 000 ppm for isopropanol;

5. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects via oral and inhalation exposure in laboratory animals;

6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 6413

In the opinion of the screening officer, certain information should not have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Remove the ACGIH TLV designation from the disclosed exposure limit value for nuisance dusts.

Registry Number 6414

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of ammonium benzoate in the controlled product, its CAS Registry Number 1863-63-4 and its percent concentration;

2. Remove the entry for molybdenum, CAS No. 7439-98-7, in the hazardous ingredients section and disclose the presence of the confidential hazardous ingredient molybdenum salt, instead. Disclose that its real chemical identity is included in the claim for exemption;

3. Clarify that the ACGIH TWA Exposure Limit Value of 5 ppm shown on the MSDS for the hazardous ingredient n-butylamine is a recommended "ceiling level";

4. Disclose the Exposure Limit Value ACGIH TLV–TWA = 5 mg/m³ (as Mo) for the confidential hazardous ingredient molybdenum salt;

5. Disclose an LD₅₀ (oral, rat) value of 365.7 mg/kg and an LD₅₀ (dermal, male guinea pig) value of 0.58 mL/kg for n-butylamine;

6. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

7. Disclose that subchronic ingestion of an ingredient in the controlled product has been shown to cause liver and kidney damage in laboratory animals;

8. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 30 minutes;

9. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6420

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that chronic inhalation of the vapours of an ingredient in the controlled product has been shown to cause adverse CNS effects in humans;

2. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vivo.

Registry Number 6475

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause bleeding in the thymus and the pancreas in laboratory animals;

2. Disclose that subchronic inhalation of an ingredient in the controlled product has been shown to cause damage to the respiratory tract and olfactory epithelia in laboratory animals;

3. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink. Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

6. Remove the notation in section 11 indicating that information pertaining to teratogenicity is not available;

7. Remove the notation in section 11 indicating that information pertaining to toxicologically synergistic products is not available.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6482 to 6486, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Values TWA = 200 ppm and STEL = 400 ppm for alcohol 1;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Registry Number 6484: Disclose that a second ingredient in the controlled product has shown positive test results in an in vivo Bone Marrow Chromosome Aberration screening test for mutagenicity;

4. Registry Numbers 6482, 6484, 6485 and 6486: If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Number 6648

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg for solvent naphtha (petroleum), heavy aromatic.

Registry Number 6677

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Clarify that the ACGIH TWA Exposure Limit Value of 100 ppm shown on the MSDS for the hazardous ingredient n-amyl acetate is actually a "STEL" value and further disclose the Exposure Limit Value ACGIH TLV–TWA = 50 ppm for the same ingredient;

2. Disclose the Exposure Limit Value AIHA WEEL (TWA, 8 hours) = 100 ppm for propylene glycol methyl ether acetate;

3. Disclose the lower Exposure Limit Value ACGIH TLV–TWA = 20 ppm for toluene;

4. Disclose that acute dermal exposure to an ingredient in the controlled product has caused skin corrosion and renal failure;

5. Disclose that acute inhalation of an ingredient in the controlled product has caused CNS effects in humans and that chronic inhalation has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

6. In relation to the first aid information for eye contact already disclosed on the MSDS, add a statement to the effect that medical attention be obtained immediately;

7. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing. If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

8. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes. Also disclose that contaminated clothing, footwear and leather goods should be removed under running water;

9. Disclose an LD₅₀ (oral, rat) value of 10 600 mg/kg and an LC₅₀ (4 hours, rat) value of 31 600 ppm for ethanol;

10. Disclose an LD₅₀ (oral, rat) value of 2.51 g/kg for n-butyl alcohol;

11. Disclose an LD₅₀ (oral, rat) value of 7 000 mg/kg for n-amyl acetate;

12. Disclose an LD₅₀ (oral, rat) value of 2 900 mg/kg for phenol-formaldehyde resin;

13. Disclose an LD₅₀ (rabbit, dermal) value of 14.1 mL/kg and an LC₅₀ (4 hours, female rat) value of 5 100 ppm for toluene;

14. Disclose that an ingredient in the controlled product is considered to be a germ cell mutagen based on positive results in in vivo screening tests and that it has been shown to cause mutagenic effects in human cells, in vitro;

15. Disclose that acetylsalicylic acid synergistically enhances the hearing loss caused by exposure to toluene in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the above-noted claims, with the exceptions of those claims bearing Registry Numbers 6170, 6306, 6413 and 6635, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

In the case of the claims bearing Registry Numbers 6170, 6306 and 6413, the screening officer has ordered the claimant to comply with the provisions of the Occupational Health and Safety Code 2006 of the Province of Alberta, except that the information in respect of which the claims for exemption were made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer, within the respective time period specified in the foregoing paragraph.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the acting Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-993-4429.

R. BOARDMAN
Chief Screening Officer

[5-1-o]